JP Morgan Chase’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2M Buy
823,513
+624,152
+313% +$20.5M ﹤0.01% 1984
2025
Q4
$7.46M Buy
199,361
+25,353
+15% +$834K ﹤0.01% 2964
2025
Q3
$4.8M Sell
174,008
-19,842
-10% -$684K ﹤0.01% 3408
2025
Q2
$6.13M Sell
193,850
-290,947
-60% -$9.36M ﹤0.01% 2972
2025
Q1
$16.1M Buy
484,797
+248,915
+106% +$8.92M ﹤0.01% 2096
2024
Q4
$8.12M Buy
235,882
+5,454
+2% +$187K ﹤0.01% 2895
2024
Q3
$9.22M Buy
230,428
+93,622
+68% +$3.29M ﹤0.01% 2680
2024
Q2
$4.13M Buy
136,806
+93,967
+219% +$2.83M ﹤0.01% 3179
2024
Q1
$1.44M Sell
42,839
-80,065
-65% -$2.57M ﹤0.01% 4086
2023
Q4
$3.97M Buy
122,904
+44,036
+56% +$1.23M ﹤0.01% 3290
2023
Q3
$2.58M Sell
78,868
-24,240
-24% -$842K ﹤0.01% 3364
2023
Q2
$3.63M Buy
103,108
+48,914
+90% +$1.69M ﹤0.01% 3113
2023
Q1
$1.77M Sell
54,194
-38,611
-42% -$1.76M ﹤0.01% 3623
2022
Q4
$5.11M Sell
92,805
-23,480
-20% -$1.29M ﹤0.01% 2793
2022
Q3
$5.15M Buy
116,285
+19,322
+20% +$942K ﹤0.01% 2715
2022
Q2
$4.73M Buy
96,963
+71,620
+283% +$3.22M ﹤0.01% 2835
2022
Q1
$1.23M Buy
25,343
+3,017
+14% +$123K ﹤0.01% 4117
2021
Q4
$953K Buy
22,326
+12,806
+135% +$510K ﹤0.01% 4428
2021
Q3
$365K Sell
9,520
-617
-6% -$19.9K ﹤0.01% 4905
2021
Q2
$285K Sell
10,137
-6,985
-41% -$210K ﹤0.01% 5043
2021
Q1
$565K Sell
17,122
-2,366
-12% -$83K ﹤0.01% 4603
2020
Q4
$704K Buy
19,488
+19,102
+4,949% +$771K ﹤0.01% 4169
2020
Q3
$12K Buy
+386
New +$14.1K ﹤0.01% 5235

Other funds holding HRMY